SCHEMBL6488544

SCHEMBL6488544

CCN(C)OC(=O)c1csc(N(C(=O)c2ccccc2Cl)c2ccc(Cl)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 2/20 0.42
HTT P42858 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 2/20 0.40
TP53 P04637 1/20 0.39
DHODH Q02127 3/20 0.36
MAPT P10636 4/20 0.36
POLB P06746 2/20 0.36
NPC1 O15118 1/20 0.36
CYP3A4 P08684 1/20 0.36
CFTR P13569 1/20 0.35
EGFR P00533 1/20 0.33
PTPRB P23467 1/20 0.33
S1PR1 P21453 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5035190 0.87 MAPT (0.49) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL5034815 0.86 KDM4E (0.43) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL5032555 0.83 ALDH1A1 (0.44) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL5032531 0.82 KDM4E (0.41) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL5032616 0.82 KDM4E (0.41) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL27664671 0.82 MAPT (0.39) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL5038951 0.82 KDM4E (0.43) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL5034980 0.81 KDM4E (0.47) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL5035874 0.81 KDM4E (0.40) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2
SCHEMBL5035132 0.80 KDM4E (0.45) ALDH1A1RAB9AHTTNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153962-A1 Thiazole derivatives CNR1, CNR2, GPR119 ALDH1A1 473/4885RAB9A 1847/4885HTT 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.